Actinium Pharmaceuticals, Inc. (ATNM)

1.20 +0.02 (+1.69%) USD  |  NYAM  |  Mar 06, 16:00
1.19 -0.01 (-0.83%) After-Hours: 20:00
More

Actinium Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Assertio Holdings, Inc. Upgrade
Altimmune, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Avanos Medical, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade